Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc.

Published: Aug 14, 2012

MAPLE GROVE, Minn.--(BUSINESS WIRE)--Upsher-Smith Laboratories, Inc. today announced that on Tuesday, August 14, 2012 it completed its acquisition of UK-based Proximagen Group plc (AIM: PRX), a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system (CNS) and inflammation. The acquisition was approved by Proximagen’s shareholders.

Back to news